These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7026348)

  • 1. The clonidine withdrawal syndrome. Its reproduction and evaluation in laboratory animal models.
    Thoolen MJ; Timmermans PB; van Zwieten PA
    Gen Pharmacol; 1981; 12(5):303-8. PubMed ID: 7026348
    [No Abstract]   [Full Text] [Related]  

  • 2. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal syndrome after continuous infusion of clonidine in the normotensive rat.
    Thoolen MJ; Timmermans PB; Van Zwieten PA
    J Pharm Pharmacol; 1981 Apr; 33(4):232-5. PubMed ID: 6115906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central aminergic mechanisms associated with the clonidine withdrawal syndrome.
    Lewis SJ; Fennessy MR; Taylor DA
    Clin Exp Pharmacol Physiol; 1981; 8(5):489-95. PubMed ID: 7198946
    [No Abstract]   [Full Text] [Related]  

  • 5. The withdrawal of centrally acting antihypertensives in dogs.
    Clough DP; Keddie J; Pettinger SJ
    Arzneimittelforschung; 1981; 31(11):1878-80. PubMed ID: 7198468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of salbutamol and the PDE-inhibitor RA 642 on the clonidine withdrawal syndrome in rats.
    Jonkman FA; Thoolen MJ; Wilffert B; de Jonge A; Timmermans PB; Van Zwieten PA
    J Auton Pharmacol; 1984 Sep; 4(3):199-206. PubMed ID: 6092386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central alpha-adrenergic control of blood pressure. Effects of clonidine withdrawal.
    Augustine SJ; Tachikawa S; Lokhandwala MF; Buckley JP
    Chest; 1983 Feb; 83(2 Suppl):328-31. PubMed ID: 6295708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yohimbine-precipitated clonidine withdrawal: an experimental model of the antihypertensive drug withdrawal syndrome.
    Penning DH; Jhamandas K
    Can J Physiol Pharmacol; 1992 Jun; 70(6):853-8. PubMed ID: 1358421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the clonidine withdrawal syndrome in the normotensive rat.
    DiStefano P; Fox G; Johnson EM
    J Pharmacol Exp Ther; 1980 Aug; 214(2):263-8. PubMed ID: 6104723
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of an animal model for the study of antihypertensive agents.
    Lublin CB; Conolly ME
    Proc West Pharmacol Soc; 1984; 27():333-6. PubMed ID: 6541789
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal of clonidine: effects of varying dosage or duration of treatment on subsequent blood pressure and heart rate responses.
    Oates HF; Stoker LM; Monaghan JC; Stokes GS
    J Pharmacol Exp Ther; 1978 Aug; 206(2):268-73. PubMed ID: 28415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on clonidine and guanfacine withdrawal after short term treatment in the rat.
    Barber ND; Reid JL
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):112-8. PubMed ID: 6758716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal syndromes following cessation of treatment with antihypertensive drugs.
    Parker M; Atkinson J
    Gen Pharmacol; 1982; 13(2):79-85. PubMed ID: 6284584
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggravation of the severity of the clonidine withdrawal syndrome in conscious rats by beta 2-adrenoceptor antagonists.
    Jonkman FA; van Zwieten PA
    Drugs; 1990; 40 Suppl 4():45-7. PubMed ID: 1982655
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
    Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
    Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation syndrome after continuous infusion of clonidine in the spontaneously hypertensive rat.
    Thoolen MJ; Timmermans PB; van Zwieten PA
    Life Sci; 1981 May; 28(19):2103-9. PubMed ID: 7195968
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of clonidine rebound syndrome with sublingual captopril.
    Hauger-Klevene JH
    N Engl J Med; 1986 Jan; 314(3):181-2. PubMed ID: 3510386
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac arrhythmias after abrupt clonidine withdrawal.
    Peters RW; Hamilton BP; Hamilton J; Kuzbida G; Pavlis R
    Clin Pharmacol Ther; 1983 Oct; 34(4):435-9. PubMed ID: 6617064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats.
    Salzmann R
    J Pharm Pharmacol; 1979 Apr; 31(4):212-6. PubMed ID: 36458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.